| SKU | ISG005713 |
| Brand | Ozempic |
| Categories | Medication & Treatments |
| Color | black |
| Concentrations | 1 Mg |
| Shop by Concerns | High Blood Sugar |
| Gender | Neutral |
| Shop By Goals | Blood Thinning |
| Imported Or Local | Local |
| Ingredient | Semaglutide |
| Specialty | Clinically Tested Once Weekly Prescription only |
| Sub Categories | Insulin And Diabetic Medicines |
| Warning | Caution in pancreatitis history Not for Type 1 Diabetes or Ketoacidosis Use under medical supervision only Risk of hypoglycemia |
Ozempic Pre-Filled Pen 1 Mg
Description:
Ozempic 1 mg pre-filled pen is a prescription antidiabetic medicine used for the treatment of adults with type 2 diabetes mellitus. It contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that helps improve blood sugar control by enhancing glucose-dependent insulin secretion, reducing inappropriate glucagon release, and slowing gastric emptying. Ozempic is administered once weekly by subcutaneous injection using a ready-to-use pre-filled pen designed for convenient, accurate dosing as part of a comprehensive diabetes management plan including diet, exercise, and other medications as prescribed by a healthcare professional.
Indications:
- Management of type 2 diabetes mellitus in adults to improve glycemic control.
- Reduction of elevated fasting and postprandial blood glucose levels when diet and exercise alone are insufficient.
- May be used as monotherapy or in combination with other antidiabetic agents such as metformin, sulfonylureas, SGLT2 inhibitors, or basal insulin, as directed by a physician.
- Helps reduce diabetes-related symptoms associated with poor glycemic control such as excessive thirst, frequent urination, and fatigue (as part of overall blood sugar management).
Active Ingredients / Key Components:
- Semaglutide – 1 mg per dose (glp-1 receptor agonist).
- Other excipients: Information on full excipient list and their exact concentrations is not available in the provided data. Refer to the official package leaflet for complete composition.
Dosage & Administration / How to Use:
- Ozempic is for subcutaneous injection only. Do not administer intravenously or intramuscularly.
- Usual adult dosing regimen is once weekly, on the same day each week, with or without food. The specific starting dose, titration schedule, and maintenance dose must be determined by the prescribing physician according to current guidelines and patient response.
- Inject into the abdomen, thigh, or upper arm, rotating injection sites each week to reduce the risk of lipodystrophy or skin irritation.
- Use the pre-filled pen exactly as instructed in the patient information leaflet and by your healthcare provider. Always check the label and dose window before injection.
- If a dose is missed, follow the instructions provided by your doctor or in the official leaflet. Do not double the dose to make up for a missed injection.
- Do not share your Ozempic pen with anyone else, even if the needle is changed, to prevent cross-infection.
- Patients should continue recommended diet, physical activity, and regular blood glucose monitoring while using Ozempic.
Clinical Benefits:
- Helps significantly lower blood glucose levels in adults with type 2 diabetes when used as prescribed.
- Improves glucose-dependent insulin secretion and reduces inappropriate glucagon secretion, supporting better glycemic control.
- Slows gastric emptying, which contributes to reduced post-meal blood sugar spikes.
- Once-weekly dosing supports convenience and may improve treatment adherence compared with some daily injectable therapies.
Warnings & Contraindications:
- Use only under the supervision of a healthcare professional experienced in the management of diabetes.
- Contraindicated in patients with known hypersensitivity to semaglutide or any component of the formulation.
- Not indicated for the treatment of type 1 diabetes mellitus or for diabetic ketoacidosis.
- Use with caution in patients with a history of pancreatitis; discontinue and seek medical attention if severe abdominal pain occurs.
- Patients with severe gastrointestinal disease (e.g., severe gastroparesis) should use with caution, as GLP-1 agonists slow gastric emptying.
- Monitor renal function in patients with pre-existing kidney disease, especially if experiencing severe gastrointestinal side effects (vomiting, diarrhea) that may lead to dehydration.
- Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Your doctor will decide whether to stop Ozempic or adjust therapy.
- Inform your doctor about all other medicines you are taking, especially other antidiabetic drugs, insulin, or medications that may affect blood sugar, to reduce the risk of hypoglycemia.
- May increase the risk of hypoglycemia when used with insulin or sulfonylureas; dose adjustment of concomitant therapy may be required.
- Keep out of reach of children.
Side Effects:
- Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, and indigestion. These are often mild to moderate and may decrease over time.
- Other possible effects include headache, fatigue, dizziness, and injection site reactions (redness, swelling, itching).
- Serious but less common side effects can include pancreatitis (severe, persistent abdominal pain, sometimes radiating to the back), severe allergic reactions (rash, swelling, difficulty breathing), or significant changes in kidney function due to dehydration.
- Seek immediate medical attention if you experience symptoms of severe allergic reaction, pancreatitis, or very low blood sugar such as confusion, difficulty speaking, visual disturbances, or loss of consciousness.
Storage Instructions:
Store Ozempic pens in a refrigerator at 2–8°c before first use, protected from light. Do not freeze. After first use, storage conditions and in-use shelf life should follow the official package leaflet; typically, pens may be stored at room temperature below the maximum recommended temperature or refrigerated, away from direct heat and sunlight. Keep the cap on when not in use. Keep out of reach of children.
Specifications:
- Product type: pre-filled injectable pen for subcutaneous use.
- Active ingredient: semaglutide 1 mg per dose.
- Form: solution for injection in a pre-filled pen.
- Pack details (number of doses per pen and per pack): not specified in the provided information; refer to the product carton or leaflet for exact configuration.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.


